CID 131751658
Hovenoside g
Structural Information
- Molecular Formula
- C51H82O21
- SMILES
- CC(=CC1CC(C2C3CCC4C5(CCC(C(C5CCC4(C36CC2(O1)OC6)C)(C)C)OC7C(C(C(CO7)O)OC8C(C(C(C(O8)CO)O)O)OC9C(C(C(CO9)O)O)O)OC1C(C(C(CO1)O)O)O)C)(C)O)C
- InChI
- InChI=1S/C51H82O21/c1-22(2)14-23-15-49(7,62)41-24-8-9-30-47(5)12-11-31(46(3,4)29(47)10-13-48(30,6)50(24)20-51(41,72-23)66-21-50)68-44-40(71-43-37(61)33(57)26(54)18-64-43)38(27(55)19-65-44)69-45-39(35(59)34(58)28(16-52)67-45)70-42-36(60)32(56)25(53)17-63-42/h14,23-45,52-62H,8-13,15-21H2,1-7H3
- InChIKey
- QVKNFOCNXKZPMO-UHFFFAOYSA-N
- Compound name
- 2-[4,5-dihydroxy-2-[5-hydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 1031.5422 | 305.6 |
[M+Na]+ | 1053.5241 | 301.6 |
[M+NH4]+ | 1048.5687 | 303.7 |
[M+K]+ | 1069.4981 | 311.2 |
[M-H]- | 1029.5276 | 298.5 |
[M+Na-2H]- | 1051.5096 | 318.5 |
[M]+ | 1030.5344 | 302.7 |
[M]- | 1030.5354 | 302.7 |